Onepot AI emerged from stealth with $13M in funding to accelerate small-molecule synthesis for drug discovery. The company built POT-1, an automated synthesis lab, and Phil, an AI chemist that learns from real-world experiments rather than literature data. Their platform allows biotech and pharma companies to order custom
Sort: